09/09/2026
The biggest challenge in researching rare diseases lies not only in diagnosis and treatment but also in developing appropriate models to test potential drug molecules and interventions. Factors such as the young age of affected children, the rarity of the condition, and limited funding all contribute to these challenges. However, we are actively working to overcome these barriers.
We have brought children from various parts of the world to our platform and created neuronal models to accelerate the pace of research.
Contact us to learn more about our platform for mitochondrial rare diseases.
https://hubs.la/Q04x068f0
Stemnovate Limited